New hope for tough lymphoma: drug combo trial launches
Disease control
Not yet recruiting
This study tests a combination of two drugs, mitoxantrone hydrochloride liposome and enlonstobart, in people with peripheral T-cell lymphoma that has come back or not responded to treatment. The goal is to find the safest and most effective dose and see how well the combo works. …
Phase: PHASE1, PHASE2 • Sponsor: Sun Yat-Sen University Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC